Insulet Earnings Estimate

PODD Stock  USD 320.91  2.55  0.79%   
The next projected EPS of Insulet is estimated to be 1.166975 with future projections ranging from a low of 1.1125 to a high of 1.22065. Insulet's most recent 12-month trailing earnings per share (EPS TTM) is at 3.27. Please be aware that the consensus of earnings estimates for Insulet is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Insulet is projected to generate 1.166975 in earnings per share on the 31st of December 2025. Insulet earnings estimates show analyst consensus about projected Insulet EPS (Earning Per Share). It derives the highest and the lowest estimates based on Insulet's historical volatility. Many public companies, such as Insulet, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Insulet Revenue Breakdown by Earning Segment

By analyzing Insulet's earnings estimates, investors can diagnose different trends across Insulet's analyst sentiment over time as well as compare current estimates against different timeframes. The current year's Gross Profit is expected to grow to about 1.5 B. The current year's Pretax Profit Margin is expected to grow to 0.15Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in banks.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.

Insulet Earnings Estimation Breakdown

The calculation of Insulet's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Insulet is estimated to be 1.166975 with the future projection ranging from a low of 1.1125 to a high of 1.22065. Please be aware that this consensus of annual earnings estimates for Insulet is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.0
1.11
Lowest
Expected EPS
1.166975
1.22
Highest

Insulet Earnings Projection Consensus

Suppose the current estimates of Insulet's value are higher than the current market price of the Insulet stock. In this case, investors may conclude that Insulet is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Insulet's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2025Current EPS (TTM)
2459.79%
0.0
1.166975
3.27

Insulet Earnings per Share Projection vs Actual

Actual Earning per Share of Insulet refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Insulet predict the company's earnings will be in the future. The higher the earnings per share of Insulet, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Insulet Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Insulet, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Insulet should always be considered in relation to other companies to make a more educated investment decision.

Insulet Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Insulet's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
null
nullnullnullnull
2025-08-07
2025-06-300.921.170.2527 
2025-05-08
2025-03-310.791.020.2329 
2025-02-20
2024-12-311.0211.150.12912 
2024-11-07
2024-09-300.760.90.1418 
2024-08-08
2024-06-300.560.55-0.01
2024-05-09
2024-03-310.390.730.3487 
2024-02-22
2023-12-310.661.40.74112 
2023-11-02
2023-09-300.40.710.3177 
2023-08-08
2023-06-300.260.380.1246 
2023-05-04
2023-03-310.110.230.12109 
2023-02-23
2022-12-310.210.240.0314 
2022-11-03
2022-09-300.150.350.2133 
2022-08-04
2022-06-300.22-0.5-0.72327 
2022-05-05
2022-03-310.230.40.1773 
2022-02-23
2021-12-310.320.420.131 
2021-11-04
2021-09-300.240.18-0.0625 
2021-08-05
2021-06-300.130.230.176 
null
nullnullnullnull
2021-02-23
2020-12-31-0.04-0.040.0
2020-11-04
2020-09-300.080.170.09112 
2020-08-06
2020-06-300.0110.220.2091900 
2020-05-07
2020-03-31-0.01-0.03-0.02200 
2020-02-25
2019-12-310.110.08-0.0327 
2019-11-05
2019-09-300.030.01-0.0266 
2019-08-05
2019-06-300.020.020.0
2019-05-02
2019-03-310.010.070.06600 
2019-02-25
2018-12-310.070.160.09128 
2018-11-01
2018-09-300.020.030.0150 
2018-08-02
2018-06-30-0.13-0.030.176 
2018-05-03
2018-03-31-0.19-0.110.0842 
2018-02-21
2017-12-31-0.08-0.12-0.0450 
2017-11-02
2017-09-30-0.1-0.040.0660 
2017-08-03
2017-06-30-0.13-0.130.0
2017-05-08
2017-03-31-0.15-0.17-0.0213 
2017-02-27
2016-12-31-0.05-0.16-0.11220 
2016-11-03
2016-09-30-0.09-0.050.0444 
2016-08-03
2016-06-30-0.17-0.080.0952 
2016-04-28
2016-03-31-0.19-0.22-0.0315 
2016-02-25
2015-12-31-0.26-0.28-0.02
2015-11-05
2015-09-30-0.26-0.33-0.0726 
2015-08-12
2015-06-30-0.13-0.27-0.14107 
2015-04-30
2015-03-31-0.1-0.21-0.11110 
2015-02-26
2014-12-31-0.04-0.1-0.06150 
2014-11-05
2014-09-30-0.01-0.12-0.111100 
2014-08-07
2014-06-30-0.08-0.060.0225 
2014-05-07
2014-03-31-0.06-0.11-0.0583 
2014-02-27
2013-12-31-0.09-0.040.0555 
2013-11-07
2013-09-30-0.16-0.21-0.0531 
2013-08-07
2013-06-30-0.19-0.2-0.01
2013-05-06
2013-03-31-0.21-0.20.01
2013-02-27
2012-12-31-0.22-0.210.01
2012-11-08
2012-09-30-0.24-0.26-0.02
2012-08-08
2012-06-30-0.26-0.3-0.0415 
2012-05-09
2012-03-31-0.28-0.31-0.0310 
2012-02-09
2011-12-31-0.26-0.3-0.0415 
2011-11-03
2011-09-30-0.25-0.29-0.0416 
2011-08-02
2011-06-30-0.23-0.42-0.1982 
2011-05-09
2011-03-31-0.22-0.220.0
2011-02-15
2010-12-31-0.26-0.260.0
2010-11-09
2010-09-30-0.3-0.30.0
2010-07-29
2010-06-30-0.35-0.36-0.01
2010-05-06
2010-03-31-0.38-0.370.01
2010-02-09
2009-12-31-0.47-0.420.0510 
2009-10-26
2009-09-30-0.7-0.88-0.1825 
2009-08-04
2009-06-30-0.68-0.73-0.05
2009-05-07
2009-03-31-0.65-0.71-0.06
2009-03-05
2008-12-31-0.63-1.02-0.3961 
2008-11-06
2008-09-30-0.74-0.75-0.01
2008-08-12
2008-06-30-0.7-0.87-0.1724 
2008-05-13
2008-03-31-0.56-0.73-0.1730 
2008-03-17
2007-12-31-0.51-0.59-0.0815 
2007-11-14
2007-09-30-0.5-0.52-0.02
2007-08-14
2007-06-30-0.56-0.99-0.4376 

About Insulet Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Insulet earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Insulet estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Insulet fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings40.3 M42.3 M
Retained Earnings Total Equity-525.9 M-552.2 M
Earnings Yield 0.02  0.02 
Price Earnings Ratio 43.74  41.55 
Price Earnings To Growth Ratio 0.43  0.45 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Insulet is a strong investment it is important to analyze Insulet's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insulet's future performance. For an informed investment choice regarding Insulet Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in banks.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.88)
Earnings Share
3.27
Revenue Per Share
33.594
Quarterly Revenue Growth
0.329
Return On Assets
0.0775
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.